Please note that the contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
For Investors Relations news and news releases from Fujifilm and FUJIFILM Business Innovation for 2019 and before, please click：
- Aug 18, 2020
- Fuji Xerox Expands CocoDesk Services to Office Buildings in an Effort to Support New Workstyles (FUJI XEROX)
- Aug 17, 2020
- FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to manufacture COVID-19 Vaccine Candidate at its Billingham site (Fujifilm)
- Jul 30, 2020
- FUJIFILM Holdings raises its target on reducing CO2 emissions for FY2030
- Jul 28, 2020
- Fujifilm launches “FUJIFILM Shoe Mount Flash EF-60” (Fujifilm)
- Jul 27, 2020
- FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing (Fujifilm)
- Jul 27, 2020
- Centus Biotherapeutics Announces Positive CHMP Opinion for FKB238, Biosimilar Bevacizumab (Fujifilm)
- Jul 23, 2020
-
Novavax and FUJIFILM Diosynth Biotechnologies Initiate
Large Scale Manufacturing of COVID-19 Vaccine Candidate (Fujifilm) - Jul 20, 2020
-
Fujifilm wins internationally prestigious
“Red Dot Award: Brands & Communication Design 2020” (Fujifilm) - Jul 17, 2020
- Disaster Relief Donation for People Affected by the Heavy Rain Event of July 2020
- Jul 16, 2020
- Fujifilm develops “FUJIFILM PROJECTOR Z8000” (Fujifilm)
- Jul 9, 2020
- Mylan and Fujifilm Kyowa Kirin Biologics Announce U.S. FDA Approval of Hulio® (adalimumab-fkjp) (Fujifilm)
- Jul 9, 2020
- Fujifilm develops high-performance multispectral camera system (Fujifilm)
- Jul 1, 2020
- Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan (Fujifilm)
- Jun 30, 2020
- Fujifilm releases FUJINON Lens GF30mmF3.5 R WR (Fujifilm)
- Jun 29, 2020
- Fujifilm Kyowa Kirin Biologics Announces Approval of “Adalimumab (Genetical Recombination) [Adalimumab Biosimilar 1]” in Japan (Fujifilm)
- Jun 9, 2020
- Fujifilm to invest 100 billion yen (928 million USD) to expand its large scale biologics production facility in Denmark (Fujifilm)
- Jun 5, 2020
- New Co-authored Book from Fujifilm Chairman Shigetaka Komori and Professor Philip Kotler Published
- Jun 4, 2020
- Fujifilm invests in a biotech venture, Rege Nephro (Fujifilm)